Glucocorticoid Receptor Antagonists

Cat.No. Product Name Information Product Use Citations Product Validations
S6608 AL082D06 AL082D06 is a nonsteroidal glucocorticoid receptor (GR) antagonist with no detectable binding affinity for the highly related receptors for mineralocorticoids, androgens, estrogens, and progestins.
eLife, 2025, e93183
International Journal of Molecular Sciences, 2023, 11700
Int J Mol Sci, 2023, 24(14)11700
S2606 Mifepristone (RU-486) Mifepristone is a remarkably active antagonist of progesterone receptor and glucocorticoid receptor with IC50 of 0.2 nM and 2.6 nM, respectively. Mifepristone promotes cell autophagy and apoptosis, decreases Bcl-2 level and increases Beclin1 level, accompanied by weakened interaction between Bcl-2 and Beclin1.Mifepristone (RU486) can be used to induce animal models of Spontaneous Abortion.
Pharmacol Res, 2025, 215:107696
Cell Death Dis, 2025, 16(1):237
J Virol, 2025, 99(2):e0147224
Verified customer review of Mifepristone (RU-486)
E1091 Relacorilant (CORT125134) Relacorilant (CORT125134) is a potent, selective and orally bioavailable glucocorticoid receptor antagonist, with a Ki of 7.2 nM in HepG2 TAT assay, and also shows Kis of 12, 81.2, 210 nM for rat, human and monkey glucocorticoid receptor in cell-based assay, respectively.
Biomed Pharmacother, 2024, 180:117523
Journal of Endocrinological Investigation, 2023, 1-14
J Endocrinol Invest, 2023, 10.1007/s40618-023-02184-3